招銀國際:首次覆蓋平安好醫生(1833.HK)給予“買入”評級,目標價149.5港元
格隆匯6月17日丨招銀國際今日發佈最新研報稱,平安好醫生利用其頗具規模的內部醫療團隊和其特有的基於人工智能的醫療系統,為用户提供及時的高質量醫療服務。涵蓋7*24小時的點對點服務,包括在線諮詢、開處方、轉診、就診預約、第2診療意見和快達1小時的藥品快遞服務。公司還提供綜合性的消費者醫療服務、在線健康商城、健康管理和健康交互服務。
截至2019年,平安好醫生擁有3.152億註冊用户,日均諮詢量為72.9萬,成為中國最大的移動醫療APP。與其他主要的在線醫療平台相比,平安好醫生擁有更大的線上流量、更高的用户粘性和更大的新用户獲取能力。
招銀國際認為,平安好醫生於在線醫療諮詢服務中的強大競爭力決定了其在市場中的領導地位。招銀國際首次覆蓋平安好醫生給予“買入”評級,目標價149.5港元,較昨日收盤價112.9港元有32.4%的潛在升幅。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.